ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 782

Oligoarticular Juvenile Idiopathic Arthritis Displayed Increased Expression of Co-Inhibitory Receptors Without Signs of T-Cell Exhaustion

Erdal Sag1, Selcan Demir 2, Morten A. Nielsen 3, Malene Hvid 4, Egemen Turhan 5, Yelda Bilginer 2, Seza Ozen 6 and Bent Deleuran 7, 1Hacettepe University, Ankara, Turkey, 2Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University, Ankara, Turkey, 3Department of Biomedicine, Aarhus University, Aarhus, Denmark, 4Department of Biomedicine; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, 5Department of Orthopedics and Traumatology, Hacettepe University, Ankara, Turkey, 6Hacettepe University Hospital, Ankara, Turkey, 7Department of Biomedicine; Department of Rheumatology, Aarhus University, Aarhus, Denmark

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Ex-vivo arthritis model and LAG-3, fibroblast-like synoviocytes, juvenile idiopathic arthritis (JIA), T cell exhaustion

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Pediatric Rheumatology – ePoster I: Basic Science, Biomarkers, & Sclerodermic Fever

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Activated T cells are involved in the pathogenesis of the synovitis in oligoarticular Juvenile Idiopathic Arthritis (o-JIA). T cell activation is counter-balanced via co-inhibitory receptors (co-IRs) such as CTLA-4, PD-1, LAG-3, and TIM-3. Here we identify the role of co-IRs in the pathogenesis of o-JIA.

Methods: Paired synovial fluid (SF) and plasma, PBMCs and SFMCs, were obtained from o-JIA patients together with clinical data (n=14). Plasma from healthy controls (HC, n=14) and paired SF and plasma from 5 children requiring arthroscopy for non-inflammatory orthopaedic problems (OC, n=5) served as controls. Soluble levels of co-IRs were measured by ELISA and their cellular expression by flow cytometry. Spontaneously differentiated fibroblast-like synoviocytes (FLS) from SFMCs were co-cultured with autologous PBMCs/SFMCs and used as an ex-vivo disease models. Functional effects of co-IRs were evaluated via blocking them with checkpoint inhibitors in these ex-vivo disease models.

Results: o-JIA patients had increased soluble levels (Figure 1A) and CD3+CD4+CD45RO+ T cell surface expressions of sPD-1, sLAG-3, sTIM-3, but not sCTLA-4 in SF compared with plasma (Figure 1B). Plasma and SF levels of sLAG-3 and TIM-3, but not sPD-1 levels were higher in o-JIA patients compared with controls. (Figure 1A) None of the soluble co-IR levels correlated with disease activity. As CD4 T cell exhaustion is an outcome of continued antigen presentation, we examined if MHC-class II expression was present on these FLS. FLS expressed nearly no MHC-class II molecules in monocultures, but this was readily detected when co-cultured with PBMCs and SFMCs together with an increased Monocyte Chemoattractant Protein-1 (MCP-1) production. (Figure 2A) Only anti-LAG3 antibodies significantly increased the MCP-1 production in PBMC monocultures and FLS+PBMC co-cultures. (Figure 2B) PBMCs and SFMCs produced significantly higher levels of IFN-ɣ after CD3/CD28 activation (p< 0.001), but they were not affected by the addition of antibody towards the other checkpoint inhibitors. Conclusion: This is the first report studying the effects of different co-IRs in o-JIA. Both the soluble levels and the surface expressions of co-IRs were higher at the site of inflammation in o-JIA. SFMCs and PBMCs of o-JIA patients are not exhausted, based on their ability to respond to CD3/CD28 activation. This is opposite to what has been shown in adult inflammatory arthritis. Co-cultures of autologous FLSs and PBMCs/SFMCs may serve as an ex-vivo arthritis model to perform functional analysis. LAG-3 might play a role in o-JIA pathogenesis and maybe a potential therapeutic option.


Figure 1

Figure 1.
A. Soluble Levels of Co-inhibitor Receptors In Oligoarticular JIA -n=14-, Non-inflammatory Juvenile Orthopaedic Controls -n=5- And Healthy Controls -n=14- In Plasma and SF
B. Surface expressions of Co-inhibitor Receptors In JIA PBMC and SFMCs -n=12-
-HC: Healthy Control, OC: Non-Inflammatory Juvenile Orthopedic Controls, JIA: Juvenile Idiopathic Arthritis, SF: synovial fluid, PBMC: Peripheral Blood Mononuclear Cells; SFMC: Synovial Fluid Mononuclear Cells, MFI: Median Fluorescence Intensity, sPD-1: soluble Programmed Death-1, sLAG-3: soluble Lymphocyte Activation Gene 3, sTIM-3: soluble T cell Immunoglobulin Mucin 3, CTLA-4: Cytotoxic T-Lymphocyte associated Antigen 4; Boxes indicate median and IQR, whiskers indicate 10th–90th percentiles*p<0.05; **p<0.01; ***p<0.001-


Figure 2

Figure 2. MCP-1 levels in the co-culture supernatants of ex vivo arthritis model -n=7-. A. Spontaneous production of MCP-1 in ex-vivo arthritis model -***p<0.001-. B. MCP-1 production after addition of neutralizing antibodies against CTLA-4, PD-1, LAG-3, TIM-3, expressed as mean fold change to isotype control -**p<0.01-.
-FLS: Fibroblast-Like Synoviocytes PBMC: Peripheral Blood Mononuclear Cells; SFMC: Synovial Fluid Mononuclear Cell; MCP-1: Monocyte Chemoattractant Protein-1 Cells CTLA-4: Cytotoxic T-Lymphocyte associated Antigen 4, PD-1: Programmed Death-1, LAG-3: Lymphocyte Activation Gene 3, TIM-3: T cell Immunoglobulin Mucin 3-


Disclosure: E. Sag, AbbVie, 2; S. Demir, None; M. Nielsen, None; M. Hvid, None; E. Turhan, None; Y. Bilginer, AbbVie, 2; S. Ozen, Enzyvant, 8; B. Deleuran, None.

To cite this abstract in AMA style:

Sag E, Demir S, Nielsen M, Hvid M, Turhan E, Bilginer Y, Ozen S, Deleuran B. Oligoarticular Juvenile Idiopathic Arthritis Displayed Increased Expression of Co-Inhibitory Receptors Without Signs of T-Cell Exhaustion [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/oligoarticular-juvenile-idiopathic-arthritis-displayed-increased-expression-of-co-inhibitory-receptors-without-signs-of-t-cell-exhaustion/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oligoarticular-juvenile-idiopathic-arthritis-displayed-increased-expression-of-co-inhibitory-receptors-without-signs-of-t-cell-exhaustion/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology